33J-21358-06088
3 vaccinations
2 coded responses
31 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 452 / OH
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- Asian
- Ethnicity
- N/A
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
-
2021-03-28
Dose 2 — Pfizer-BioNTech
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Joint pains, Muscle or body achesAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-05-09
-
2021-06-28
Survey response — 3 months, dose 2MedDRA: Headache, Palpitations — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Palpitation and severe headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-28
-
2021-12-29
Dose 3 — Pfizer-BioNTech
-
2022-01-05
Health check-in — day 7, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-11
-
2022-03-30
Survey response — 3 months, dose 3MedDRA: Headache, Nasopharyngitis, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Body ache, head ache,coldsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-06
- 2022-07-01
- 2022-12-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-30 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Palpitation and severe headache
Release 11 — 3 months, dose 3
Symptoms: Body ache, head ache,colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release